Rare diseases
Investigational molecules
Locations
Innovation House, Innovation Way, Discovery Park, CT13 9FF, United Kingdom
Clinical research is centered on advanced solid tumors, with interest in treatment settings where disease control and tumor response remain limited.
The sponsor’s activity in this area reflects a focus on cancer therapeutics and the evaluation of targeted approaches for difficult-to-treat solid malignancies.
Ottimo Pharma Limited runs clinical trials in conditions such as Neoplasm malignant, Neoplasm, among others.
Clinical trials run by this sponsor – those enrolling participants first.
IrelandIncrease visibility for your trials and help patients find your site through our platform.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
